These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 26317997

  • 1. Inhibition of mTORC1 Enhances the Translation of Chikungunya Proteins via the Activation of the MnK/eIF4E Pathway.
    Joubert PE, Stapleford K, Guivel-Benhassine F, Vignuzzi M, Schwartz O, Albert ML.
    PLoS Pathog; 2015 Aug; 11(8):e1005091. PubMed ID: 26317997
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
    Wang X, Yue P, Chan CB, Ye K, Ueda T, Watanabe-Fukunaga R, Fukunaga R, Fu H, Khuri FR, Sun SY.
    Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Simultaneous inhibition of mTOR-containing complex 1 (mTORC1) and MNK induces apoptosis of cutaneous T-cell lymphoma (CTCL) cells.
    Marzec M, Liu X, Wysocka M, Rook AH, Odum N, Wasik MA.
    PLoS One; 2011 Nov; 6(9):e24849. PubMed ID: 21949767
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis C virus NS5A binds to the mRNA cap-binding eukaryotic translation initiation 4F (eIF4F) complex and up-regulates host translation initiation machinery through eIF4E-binding protein 1 inactivation.
    George A, Panda S, Kudmulwar D, Chhatbar SP, Nayak SC, Krishnan HH.
    J Biol Chem; 2012 Feb 10; 287(7):5042-58. PubMed ID: 22184107
    [Abstract] [Full Text] [Related]

  • 6. Differential Phosphatidylinositol-3-Kinase-Akt-mTOR Activation by Semliki Forest and Chikungunya Viruses Is Dependent on nsP3 and Connected to Replication Complex Internalization.
    Thaa B, Biasiotto R, Eng K, Neuvonen M, Götte B, Rheinemann L, Mutso M, Utt A, Varghese F, Balistreri G, Merits A, Ahola T, McInerney GM.
    J Virol; 2015 Nov 10; 89(22):11420-37. PubMed ID: 26339054
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The synergistic inhibition of breast cancer proliferation by combined treatment with 4EGI-1 and MK2206.
    Wang H, Huang F, Wang J, Wang P, Lv W, Hong L, Li S, Zhou J.
    Cell Cycle; 2015 Nov 10; 14(2):232-42. PubMed ID: 25607647
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. mTORC1 signalling and eIF4E/4E-BP1 translation initiation factor stoichiometry influence recombinant protein productivity from GS-CHOK1 cells.
    Jossé L, Xie J, Proud CG, Smales CM.
    Biochem J; 2016 Dec 15; 473(24):4651-4664. PubMed ID: 27760840
    [Abstract] [Full Text] [Related]

  • 11. West nile virus-induced activation of mammalian target of rapamycin complex 1 supports viral growth and viral protein expression.
    Shives KD, Beatman EL, Chamanian M, O'Brien C, Hobson-Peters J, Beckham JD.
    J Virol; 2014 Aug 15; 88(16):9458-71. PubMed ID: 24920798
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increased milk protein synthesis in response to exogenous growth hormone is associated with changes in mechanistic (mammalian) target of rapamycin (mTOR)C1-dependent and independent cell signaling.
    Sciascia Q, Pacheco D, McCoard SA.
    J Dairy Sci; 2013 Apr 15; 96(4):2327-2338. PubMed ID: 23462168
    [Abstract] [Full Text] [Related]

  • 14. The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer.
    D'Abronzo LS, Bose S, Crapuchettes ME, Beggs RE, Vinall RL, Tepper CG, Siddiqui S, Mudryj M, Melgoza FU, Durbin-Johnson BP, deVere White RW, Ghosh PM.
    Oncogene; 2017 Nov 16; 36(46):6359-6373. PubMed ID: 28745319
    [Abstract] [Full Text] [Related]

  • 15. Regulatory effects of a Mnk2-eIF4E feedback loop during mTORC1 targeting of human medulloblastoma cells.
    Eckerdt F, Beauchamp E, Bell J, Iqbal A, Su B, Fukunaga R, Lulla RR, Goldman S, Platanias LC.
    Oncotarget; 2014 Sep 30; 5(18):8442-51. PubMed ID: 25193863
    [Abstract] [Full Text] [Related]

  • 16. A unifying model for mTORC1-mediated regulation of mRNA translation.
    Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM.
    Nature; 2012 May 02; 485(7396):109-13. PubMed ID: 22552098
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inactivation of the mTORC1-eukaryotic translation initiation factor 4E pathway alters stress granule formation.
    Fournier MJ, Coudert L, Mellaoui S, Adjibade P, Gareau C, Côté MF, Sonenberg N, Gaudreault RC, Mazroui R.
    Mol Cell Biol; 2013 Jun 02; 33(11):2285-301. PubMed ID: 23547259
    [Abstract] [Full Text] [Related]

  • 19. Newcastle Disease virus infection activates PI3K/Akt/mTOR and p38 MAPK/Mnk1 pathways to benefit viral mRNA translation via interaction of the viral NP protein and host eIF4E.
    Zhan Y, Yu S, Yang S, Qiu X, Meng C, Tan L, Song C, Liao Y, Liu W, Sun Y, Ding C.
    PLoS Pathog; 2020 Jun 02; 16(6):e1008610. PubMed ID: 32603377
    [Abstract] [Full Text] [Related]

  • 20. La-related Protein 1 (LARP1) Represses Terminal Oligopyrimidine (TOP) mRNA Translation Downstream of mTOR Complex 1 (mTORC1).
    Fonseca BD, Zakaria C, Jia JJ, Graber TE, Svitkin Y, Tahmasebi S, Healy D, Hoang HD, Jensen JM, Diao IT, Lussier A, Dajadian C, Padmanabhan N, Wang W, Matta-Camacho E, Hearnden J, Smith EM, Tsukumo Y, Yanagiya A, Morita M, Petroulakis E, González JL, Hernández G, Alain T, Damgaard CK.
    J Biol Chem; 2015 Jun 26; 290(26):15996-6020. PubMed ID: 25940091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.